Studies

  1. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

  2. Multiomics to elucidate IBD risk factors and pathways

  3. Risk Factors for Developing Inflammatory Bowel Disease Within and Across Families with a Family History of IBD

  4. Reduced *LHFPL3-AS2* lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease

  5. Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients

  6. Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

  7. Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)

  8. HLA-DRB1*01:03 and Severe Ulcerative Colitis

  9. Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease

  10. Serum Antibodies Reactive with *Saccharomyces cerevisiae* in Inflammatory Bowel Disease: Is IgA Antibody a Marker for Crohn’s Disease?